MARC Record from harvard_bibliographic_metadata

LEADER: 03516nam a2200481 a 4500
001 013780267-6
005 20130917150705.0
008 130619s2013 gw a b 001 0 eng c
010 $a 2012554623
015 $aGBB2A0244$2bnb
016 7 $a101603329$2DNLM
016 7 $a016182865$2Uk
020 $a9783527331079 (hbk. : alk. paper)
020 $a3527331077 (hbk. : alk. paper)
020 $z9783527648238 (ePDF)
020 $z9783527648221 (ePub)
020 $z9783527648214 (mobi)
020 $z9783527648207 (oBook)
035 0 $aocn827785566
040 $aNLM$beng$cNLM$dNLE$dOCLCO$dOHX$dUKMGB$dCDX$dIXA$dGSU$dDLC
042 $apcc
050 00 $aQP551.5$b.P758 2013
060 00 $aW1$bME9613H v.56 2013
060 10 $aQU 55
245 00 $aProtein-protein interactions in drug discovery /$cedited by Alexander Dömling.
260 $aWeinheim :$bWiley-VCH,$cc2013.
300 $axxi, 314 p. :$bill. (some col.) ;$c24 cm.
490 1 $aMethods and principles in medicinal chemistry ;$vv. 56
504 $aIncludes bibliographical references and index.
505 0 $aProtein-protein interactions: an vverview / Christian Ottman -- Prediction of intra- and interspecies protein-protein interactions facilitating systems biology studies / Sylvia Schleker, Seshan Ananthasubramanian, Judith Klein-Seetharaman, Madhavi K Ganapathiraju -- Modulators of protein-protein interactions: importance of three-dimensionality / David C Fry, Sung-Sau So -- A leap into the chemical space of protein-protein interaction inhibitors / Bruno O Villoutreix, C Labbé, David Lagorce, Guillaume Laconde, Olivier Sperandio -- Interactive technologies for leveraging the known chemistry of anchor residues to disrupt protein interactions / Carlos J Camacho, David R Koes, Alexander S Dömling -- SH3 domains as drug targets / James Luccarelli, Sam Thompson, Andrew D Hamilton -- p53/MDM2 antagonists: towards nongenotoxic anticancer treatments / Kareem Khoury, Tad A Holak, Alexander Dömling -- Inhibition of LFA-1/ICAM interaction for the treatment of autoimmune diseases / Kevin M Guckian, Daniel M Scott -- The PIF pocket of AGC kinases: a target site for allosteric modulators and protein-protein interaction inhibitors / Matthias Engel -- Retosiban and epelsiban: potent and selective orally available oxytocin antagonists / Alan D Borthwick, John Liddle -- Peptidic inhibitors of protein-protein interactions for cell adhesion receptors: RGD peptides and beyond / Carlos Mas-Moruno, Horst Kessler -- REPLACE strategy for generating non-ATP-competitive inhibitors of cell cycle protein kinases / Campbell McInnes -- Index.
650 0 $aProtein-protein interactions.
650 12 $aProtein Binding.
650 22 $aDrug Discovery.
650 22 $aProtein Interaction Domains and Motifs.
700 1 $aDömling, Alexander.
776 0 $tProtein-protein interactions in drug discovery [Ressource électronique]$o978-3-527-64823-8
776 0 $tProtein-protein interactions in drug discovery [Ressource électronique]$o978-3-527-64822-1
776 0 $tProtein-protein interactions in drug discovery [Ressource électronique]$o978-3-527-64821-4
776 0 $tProtein-protein interactions in drug discovery [Ressource électronique] / edited by Alexander Dömling$dWeinheim : Wiley-VCH, 2013. (@Methods and principles in medicinal chemistry)$o978-3-527-64820-7$w(ABES)178874590
830 0 $aMethods and principles in medicinal chemistry ;$vv. 56.
899 $a415_565971
988 $a20130917
906 $0OCLC